Skip to main content
Log in

Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Navalkissoor S, Grossman A. Targeted alpha particle therapy for neuroendocrine tumours: the next generation of peptide receptor radionuclide therapy. Neuroendocrinology. 2019;108:256–64.

    CAS  PubMed  Google Scholar 

  2. Ballal S, Yadav MP, Bal C, Sahoo RK, Tripathi M. Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety. Eur J Nucl Med Mol Imaging [Internet]. European Journal of Nuclear Medicine and Molecular Imaging; 2019; Available from: http://link.springer.com/10.1007/s00259-019-04567-2.

  3. Zhang J, Kulkarni HR, Baum RP. Peptide receptor radionuclide therapy using 225Ac-DOTATOC achieves partial remission in a patient with progressive neuroendocrine liver metastases after repeated β-emitter peptide receptor radionuclide therapy. Clin Nucl Med [Internet]. 2020;45:241–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31977472.

  4. Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. An overview of targeted alpha therapy with 225Actinium and 213Bismuth. Curr Radiopharm [Internet]. 2018;11:200–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29732998.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Levent Kabasakal.

Ethics declarations

The authors declare that they have no conflict of interest. Written informed consent was obtained from the patient for the treatment procedure and for data publication. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Image of the month

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ocak, M., Toklu, T., Demirci, E. et al. Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor. Eur J Nucl Med Mol Imaging 47, 2711–2712 (2020). https://doi.org/10.1007/s00259-020-04725-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-020-04725-x

Navigation